Redeuilh Gérard, Attia Annette, Mester Jan, Sabbah Michèle
Institut National de la Santé et de la Recherche Médicale U 482, Hôpital Saint-Antoine, 184 Rue du Faubourg Saint-Antoine, 75571 Paris Cedex 12, France.
Oncogene. 2002 Aug 22;21(37):5773-82. doi: 10.1038/sj.onc.1205753.
We have investigated the interaction between the expression of p21(WAF1/CIP1/SDI1), a stoichiometric inhibitor of Cdk, and the transcriptional activity of the oestrogen receptor alpha (ER(alpha). Transient transfection experiments demonstrated that the expression of p21(WAF1/CIP1/SDI1) amplified the transcriptional activation by ER(alpha). A dominant negative mutant of Cdk2 also enhanced the ER(alpha) transcriptional activity, indicating that the underlying mechanism relies on the inhibition of Cdk2 activity and cell cycle arrest. In agreement with this conclusion, experiments with p21(WAF1/CIP1/SDI1) mutants demonstrated that the domain involved in the binding of p21(WAF1/CIP1/SDI1) to Cdks was indispensable for the modulation of ER(alpha) activity. In addition, we show that expression of p21(WAF1/CIP1/SDI1) alleviates the block on CBP function mediated by Cdk2 and in turn stimulates transcriptional activation by ER(alpha) in a CBP-histone acetyltransferase (HAT)-dependent manner. These results suggest a novel mechanism by which p21(WAF1/CIP1/SDI1) functions as an enhancer of ER(alpha) activity through the modulation of CBP function.
我们研究了细胞周期蛋白依赖性激酶(Cdk)的化学计量抑制剂p21(WAF1/CIP1/SDI1)的表达与雌激素受体α(ERα)转录活性之间的相互作用。瞬时转染实验表明,p21(WAF1/CIP1/SDI1)的表达增强了ERα的转录激活作用。Cdk2的显性负性突变体也增强了ERα的转录活性,这表明潜在机制依赖于对Cdk2活性的抑制和细胞周期停滞。与此结论一致,对p21(WAF1/CIP1/SDI1)突变体的实验表明,p21(WAF1/CIP1/SDI1)与Cdks结合的结构域对于调节ERα活性是必不可少的。此外,我们发现p21(WAF1/CIP1/SDI1)的表达减轻了由Cdk2介导的对CBP功能的阻断,进而以CBP-组蛋白乙酰转移酶(HAT)依赖的方式刺激ERα的转录激活。这些结果提示了一种新机制,即p21(WAF1/CIP1/SDI1)通过调节CBP功能作为ERα活性的增强子发挥作用。